基石药业获纳入MSCI全球指数成分股,彰显投资价值

基石药业官微
Aug 11

中国苏州,2025年8月11日——基石药业(股票代码:2616.HK),一家专注于抗肿瘤药物研发的创新驱动型生物医药企业,今日宣布,根据国际权威指数公司MSCI(明晟)最新发布的2025年8月指数审议结果,公司成功被纳入MSCI全球小盘股指数(MSCI Global Small Cap Index)成分股,相关调整将于2025年8月26日收市后正式生效。MSCI全球小盘股指数是由MSCI编制的全球...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10